PSMA PET: Current Sensitivity and A Novel Approach

At the American Society of Clinical Oncology Genitourinary Cancer Symposium, Judd W. Moul, MD, a urologist at Duke Cancer Institute, offered his insights on how the currently available prostate cancer diagnostics compare in terms of utility and sensitivity, as well as a novel PSMA PET product and approach that figures to increase sensitivity rates.